Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
512.4 INR | +2.39% | +2.43% | +0.98% |
May. 29 | Jubilant Ingrevia Limited Receives A Show Cause Notice in DRC 01 from State Tax Officer, Bharuch | CI |
May. 14 | Transcript : Jubilant Ingrevia Limited, Q4 2024 Earnings Call, May 14, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With an expected P/E ratio at 40.46 and 27.16 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.98% | 956M | B | ||
+20.38% | 68.31B | A- | ||
-1.28% | 48.49B | A- | ||
+25.20% | 44.42B | B+ | ||
+32.00% | 28.29B | A- | ||
+7.34% | 19.12B | C+ | ||
+10.50% | 16.64B | B+ | ||
-6.71% | 16B | B+ | ||
-23.40% | 15.84B | A- | ||
-21.05% | 13.51B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- JUBLINGREA Stock
- JUBLINGREA Stock
- Ratings Jubilant Ingrevia Limited